Cargando…
Transcriptional changes in response to X chromosome dosage in the mouse: implications for X inactivation and the molecular basis of Turner Syndrome
BACKGROUND: X monosomic mice (39,XO) have a remarkably mild phenotype when compared to women with Turner syndrome (45,XO). The generally accepted hypothesis to explain this discrepancy is that the number of genes on the mouse X chromosome which escape X inactivation, and thus are expressed at higher...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837040/ https://www.ncbi.nlm.nih.gov/pubmed/20122165 http://dx.doi.org/10.1186/1471-2164-11-82 |
_version_ | 1782178766158561280 |
---|---|
author | Lopes, Alexandra M Burgoyne, Paul S Ojarikre, Andrew Bauer, Julien Sargent, Carole A Amorim, António Affara, Nabeel A |
author_facet | Lopes, Alexandra M Burgoyne, Paul S Ojarikre, Andrew Bauer, Julien Sargent, Carole A Amorim, António Affara, Nabeel A |
author_sort | Lopes, Alexandra M |
collection | PubMed |
description | BACKGROUND: X monosomic mice (39,XO) have a remarkably mild phenotype when compared to women with Turner syndrome (45,XO). The generally accepted hypothesis to explain this discrepancy is that the number of genes on the mouse X chromosome which escape X inactivation, and thus are expressed at higher levels in females, is very small. However this hypothesis has never been tested and only a small number of genes have been assayed for their X-inactivation status in the mouse. We performed a global expression analysis in four somatic tissues (brain, liver, kidney and muscle) of adult 40,XX and 39,XO mice using the Illumina Mouse WG-6 v1_1 Expression BeadChip and an extensive validation by quantitative real time PCR, in order to identify which genes are expressed from both X chromosomes. RESULTS: We identified several genes on the X chromosome which are overexpressed in XX females, including those previously reported as escaping X inactivation, as well as new candidates. However, the results obtained by microarray and qPCR were not fully concordant, illustrating the difficulty in ascertaining modest fold changes, such as those expected for genes escaping X inactivation. Remarkably, considerable variation was observed between tissues, suggesting that inactivation patterns may be tissue-dependent. Our analysis also exposed several autosomal genes involved in mitochondrial metabolism and in protein translation which are differentially expressed between XX and XO mice, revealing secondary transcriptional changes to the alteration in X chromosome dosage. CONCLUSIONS: Our results support the prediction that the mouse inactive X chromosome is largely silent, while providing a list of the genes potentially escaping X inactivation in rodents. Although the lower expression of X-linked genes in XO mice may not be relevant in the particular tissues/systems which are affected in human X chromosome monosomy, genes deregulated in XO mice are good candidates for further study in an involvement in Turner Syndrome phenotype. |
format | Text |
id | pubmed-2837040 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-28370402010-03-12 Transcriptional changes in response to X chromosome dosage in the mouse: implications for X inactivation and the molecular basis of Turner Syndrome Lopes, Alexandra M Burgoyne, Paul S Ojarikre, Andrew Bauer, Julien Sargent, Carole A Amorim, António Affara, Nabeel A BMC Genomics Research Article BACKGROUND: X monosomic mice (39,XO) have a remarkably mild phenotype when compared to women with Turner syndrome (45,XO). The generally accepted hypothesis to explain this discrepancy is that the number of genes on the mouse X chromosome which escape X inactivation, and thus are expressed at higher levels in females, is very small. However this hypothesis has never been tested and only a small number of genes have been assayed for their X-inactivation status in the mouse. We performed a global expression analysis in four somatic tissues (brain, liver, kidney and muscle) of adult 40,XX and 39,XO mice using the Illumina Mouse WG-6 v1_1 Expression BeadChip and an extensive validation by quantitative real time PCR, in order to identify which genes are expressed from both X chromosomes. RESULTS: We identified several genes on the X chromosome which are overexpressed in XX females, including those previously reported as escaping X inactivation, as well as new candidates. However, the results obtained by microarray and qPCR were not fully concordant, illustrating the difficulty in ascertaining modest fold changes, such as those expected for genes escaping X inactivation. Remarkably, considerable variation was observed between tissues, suggesting that inactivation patterns may be tissue-dependent. Our analysis also exposed several autosomal genes involved in mitochondrial metabolism and in protein translation which are differentially expressed between XX and XO mice, revealing secondary transcriptional changes to the alteration in X chromosome dosage. CONCLUSIONS: Our results support the prediction that the mouse inactive X chromosome is largely silent, while providing a list of the genes potentially escaping X inactivation in rodents. Although the lower expression of X-linked genes in XO mice may not be relevant in the particular tissues/systems which are affected in human X chromosome monosomy, genes deregulated in XO mice are good candidates for further study in an involvement in Turner Syndrome phenotype. BioMed Central 2010-02-01 /pmc/articles/PMC2837040/ /pubmed/20122165 http://dx.doi.org/10.1186/1471-2164-11-82 Text en Copyright ©2010 Lopes et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Lopes, Alexandra M Burgoyne, Paul S Ojarikre, Andrew Bauer, Julien Sargent, Carole A Amorim, António Affara, Nabeel A Transcriptional changes in response to X chromosome dosage in the mouse: implications for X inactivation and the molecular basis of Turner Syndrome |
title | Transcriptional changes in response to X chromosome dosage in the mouse: implications for X inactivation and the molecular basis of Turner Syndrome |
title_full | Transcriptional changes in response to X chromosome dosage in the mouse: implications for X inactivation and the molecular basis of Turner Syndrome |
title_fullStr | Transcriptional changes in response to X chromosome dosage in the mouse: implications for X inactivation and the molecular basis of Turner Syndrome |
title_full_unstemmed | Transcriptional changes in response to X chromosome dosage in the mouse: implications for X inactivation and the molecular basis of Turner Syndrome |
title_short | Transcriptional changes in response to X chromosome dosage in the mouse: implications for X inactivation and the molecular basis of Turner Syndrome |
title_sort | transcriptional changes in response to x chromosome dosage in the mouse: implications for x inactivation and the molecular basis of turner syndrome |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837040/ https://www.ncbi.nlm.nih.gov/pubmed/20122165 http://dx.doi.org/10.1186/1471-2164-11-82 |
work_keys_str_mv | AT lopesalexandram transcriptionalchangesinresponsetoxchromosomedosageinthemouseimplicationsforxinactivationandthemolecularbasisofturnersyndrome AT burgoynepauls transcriptionalchangesinresponsetoxchromosomedosageinthemouseimplicationsforxinactivationandthemolecularbasisofturnersyndrome AT ojarikreandrew transcriptionalchangesinresponsetoxchromosomedosageinthemouseimplicationsforxinactivationandthemolecularbasisofturnersyndrome AT bauerjulien transcriptionalchangesinresponsetoxchromosomedosageinthemouseimplicationsforxinactivationandthemolecularbasisofturnersyndrome AT sargentcarolea transcriptionalchangesinresponsetoxchromosomedosageinthemouseimplicationsforxinactivationandthemolecularbasisofturnersyndrome AT amorimantonio transcriptionalchangesinresponsetoxchromosomedosageinthemouseimplicationsforxinactivationandthemolecularbasisofturnersyndrome AT affaranabeela transcriptionalchangesinresponsetoxchromosomedosageinthemouseimplicationsforxinactivationandthemolecularbasisofturnersyndrome |